Department of Neurosurgery, Brain Tumor Center, and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr., Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Department of Neurosurgery, Brain Tumor Center, and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr., Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cell Stem Cell. 2019 Jan 3;24(1):12-24. doi: 10.1016/j.stem.2018.11.012. Epub 2018 Dec 20.
Cell lines and animal models have provided the foundation of cancer research for many years. However, human pluripotent stem cells (hPSCs) and organoids are increasingly enabling insights into tumor development, progression, and treatment. Here, we review recent studies using hPSCs to elucidate the reciprocal roles played by genetic alterations and cell identity in cancer formation. We also review studies using human organoids as models that recapitulate both intra- and inter-tumoral heterogeneity to gain new insights into tumorigenesis and treatment responses. Finally, we highlight potential opportunities for cancer research using hPSC-derived organoids and genome editing in the future.
细胞系和动物模型多年来为癌症研究提供了基础。然而,人类多能干细胞(hPSCs)和类器官正越来越多地深入了解肿瘤的发生、发展和治疗。在这里,我们综述了利用 hPSCs 阐明遗传改变和细胞身份在癌症形成中的相互作用的最新研究。我们还综述了利用人类类器官作为模型来重现肿瘤内和肿瘤间异质性的研究,以深入了解肿瘤发生和治疗反应。最后,我们强调了未来利用 hPSC 衍生的类器官和基因组编辑进行癌症研究的潜在机会。